Abstract
Beta-lactam allergy is associated with suboptimal medical care and increased healthcare expenses. We hypothesize that introducing a multidisciplinary institutional beta-lactam de-labeling protocol at Children's Hospital of Pittsburgh (CHP) would lead to increased percentage of de-labeling encounters.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have